Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-004436
Filing Date
2025-07-02
Accepted
2025-07-02 16:35:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4459
  Complete submission text file 0001959173-25-004436.txt   6011
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Subject) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37372 | Film No.: 251101808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Melincoff Gwen A (Reporting) CIK: 0001614890 (see all company filings)

Type: 144